The Midwest faces some of the highest obesity rates in the country, and Traverse City is no exception. With Michigan reporting 35.4% obesity prevalence and 11.6% diabetes, the need for effective GLP-1 treatment is urgent. Tirzepatide has shown average weight loss of 20-25% of body weight of body weight in clinical trials, and Weight Method makes it accessible to Traverse City residents through a fully virtual program.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Traverse City is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Traverse City, MI. Weight Method offers compounded tirzepatide, prescribed by licensed providers, from $329/month with virtual consultations and direct-to-door shipping.
Tirzepatide works by mimicking incretin hormones that your body naturally produces after eating. It activates receptors in the brain that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. For Traverse City residents, Weight Method makes its compounded Tirzepatide program accessible through telehealth — a virtual consultation with a licensed provider, your prescription shipped to your door, and ongoing clinical support. Individual response varies, and your provider sets expectations based on your clinical profile rather than on brand-product trial figures.
Traverse City's suburban communities are hearing more about Tirzepatide through word of mouth and national media, but awareness and access are not the same thing. Weight Method makes access simple: an online assessment, a virtual provider consultation, and Tirzepatide (Mounjaro / Zepbound) delivered to your Traverse City address within days. Clinical results — 20-25% of body weight average body weight reduction — speak for themselves.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Michigan and start Tirzepatide from $329/month.
Get Started NowFree consultation. No commitment.